July 22nd 2025
There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or immunohistochemistry, Robert Kratzke, MD, says.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Age Is Not a Risk Factor for Post-Mastectomy Reconstructive Surgery
Employers Express Their Concerns With Cancer Care at the COA Summit
How Can Practices Seek Success With Oncology Payment Reform?
Dr Marianne Fazen on Why Cancer Is a Major Concern for Employers